Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoYNEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (
NASDAQ: PRE) ("Prenetics" or the "Company"), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced financial results for fourth quarter and full year ended December 31, 2025.
Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of DirectorsAppointment Strengthens Board with Deep Clinical and Commercial Expertise in Healthspan Optimization, Aligning with IM8 Growth Strategy
Formula 1 Phenom Ollie Bearman Joins Prenetics’ IM8 Health as Global Ambassador and ShareholderNEW YORK, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (
NASDAQ: PRE), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced Formula 1 phenom Ollie Bearman as its newest Global Ambassador and a shareholder. This partnership marks another milestone for IM8 as it continues to capture interest and align with world-class athletes who embody peak performance and a commitment to health excellence.
Prenetics to Report Q4 and Full Year 2025 Financial Results on Feb 18, 2026 and Host Earnings Conference CallNEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (
NASDAQ: PRE) ("Prenetics" or the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced it will release financial results for the fourth quarter and full year 2025 ended December 31, 2025 before market open on Wednesday, February 18, 2026. The Company will also hold its earnings conference call the same day at 10:00 a.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with analysts.
Prenetics Reinforces Strategic Focus on IM8, Divests Europa Business For Up to $13 MillionCompany Continues Portfolio Optimization on the Heels of Successful $72 million ACT Genomics sale
Prenetics Provides Update on Voluntary Warrant Exchange Program, Reaching 86.7% ParticipationCHARLOTTE, N.C., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (
NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced an update to its previously announced voluntary warrant exchange program.
Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital StructureCHARLOTTE, N.C., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (
NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced that it has entered into warrant exchange agreements, subject to customary closing conditions, with holders representing approximately 83.4% of its outstanding Class A and Class B warrants, pursuant to a voluntary warrant exchange program designed to simplify the Company’s capital structure and materially reduce potential future dilution.
Prenetics Announces Upcoming Conference ParticipationCHARLOTTE, N.C., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (
NASDAQ: PRE) ("Prenetics" or the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced its participation in the following upcoming investor conferences.
Prenetics Executives Announce Open Market Share Purchases Totaling Approx. $1.45 MillionCHARLOTTE, N.C., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (
NASDAQ: PRE) ("Prenetics" or the "Company"), the parent company of IM8 and a global health-tech and longevity company pioneering a dual-engine strategy across consumer wellness and Bitcoin, today announced that all key members of its executive leadership team have executed open market purchases of Prenetics’ common stock during the Company’s designated trading window.
Bitcoin Whales Unleash Torrent of Sales, Sending Market into “Extreme Fear” as Price Dips Below $100,000San Francisco, CA – November 7, 2025 – The cryptocurrency market has been gripped by a seismic shift in recent weeks, as "OG Bitcoin whales" – early adopters and long-term holders – along with major institutional players, have initiated a significant sell-off, sending Bitcoin's price tumbling below the psychological $100,000 mark. This aggressive divestment, concentrated [...]
Prenetics Announces Third Quarter 2025 Financial Results Release Date and Inaugural Earnings Conference CallCHARLOTTE, N.C., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (
NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced it will release financial results for the third quarter 2025 ended September 30, 2025 before market open on Monday, November 10, 2025. The Company will also hold its first ever earnings conference call the same day at 8:30 a.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with analysts.
Bitcoin's 'Uptober' Streak Ends: First Monthly Loss Since 2018 Signals Shifting Market DynamicsAs October 31, 2025, draws to a close, the cryptocurrency market is grappling with a significant shift: Bitcoin (BTC) is on track to record its first monthly loss in October since 2018, shattering a seven-year streak of gains affectionately dubbed "Uptober" by market participants. This unexpected downturn, with Bitcoin's price
Prenetics Closes $44 Million Equity Offering, Pioneers Dual Health and Bitcoin Treasury StrategyHong Kong, October 28, 2025 – In a significant move highlighting the accelerating trend of corporate adoption in the digital asset space, Prenetics Global Limited (
NASDAQ: PRE), a leading global diagnostics and genetic testing company, today announced the successful closing of a $44.0 million equity offering. The capital infusion is earmarked for the global expansion [...]
